| Keywords: |
signal transduction; review; cisplatin; combined modality therapy; tumor differentiation; drug resistance; cancer resistance; cell transformation, neoplastic; gene expression regulation, neoplastic; carrier proteins; tumor cell line; testicular neoplasms; gene control; protein kinase c; neoplasms, germ cell and embryonal; genes, ras; chromosome deletion; cell nucleus receptor; germ cell tumor; retinoic acid; chromosome 12q; fibroblast growth factor; genetic markers; chromosome 12p; transforming growth factor alpha; cyclic amp dependent protein kinase; tretinoin; receptors, retinoic acid; chromosomes, human, pair 12; hexamethylenebisacetamide; isochromosome; human; male; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; retinoic acid binding protein
|
